• to reduced the chance of really serious cardiovascular (coronary heart and blood vessel) issues in Grown ups with sort two diabetes and heart problemsIn October 2024, Novo Nordisk printed a research on scientific journal Mother nature a couple of novel glucose-sensitive insulin NNC2215 that may minimize the potential risk of hypoglycemia in ani